Cumulus Neuroscience
Generated by Meeveem AI
"Advanced at-home brain health monitoring platform for CNS clinical trials and neurological research."
Belfast
•11 - 50 Employees
•Digital Health
About Cumulus Neuroscience
Cumulus Neuroscience develops NeuLogiq, a medical grade platform combining EEG monitoring with cognitive, mood, language and sleep assessments to capture objective brain health data at home. The technology addresses critical gaps in CNS clinical trials, where frequent, reliable longitudinal monitoring has been difficult outside clinical settings. Formed in partnership with ten leading pharmaceutical companies including Biogen, Pfizer and GSK, Cumulus provides trial-ready digital biomarkers and AI powered analytics that accelerate treatment development for neurodegeneration and psychiatric conditions such as dementia, schizophrenia and depression.
30
Team Members
2015
Founded
Digital Health
Sector
Hybrid
Work Environment
Our Vision
A future where brain health is measured with the same precision and accessibility as heart health, enabling earlier intervention and better treatment outcomes for neurological conditions.
Our Mission
At Cumulus Neuroscience, our mission is to solve the biggest challenges in monitoring functional brain health and brain disorders, bringing life-changing therapies to patients faster and more cost effectively.